Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

2.95p
   
  • Change Today:
      0.100p
  • 52 Week High: 4.25
  • 52 Week Low: 2.85
  • Currency: UK Pounds
  • Shares Issued: 356.04m
  • Volume: 424,815
  • Market Cap: 10.50m
  • RiskGrade: 309
2015-12-23 - Suspension of Listing

1 Day Chart (23-10-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E 1.6 n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 4.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

HEMO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
28-Feb-15 n/a (0.01) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a 0.08 0.60p 6.3 n/a n/a n/a 0.0%
31-Dec-16 n/a (0.47) (0.70)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (2.36) 1.90p 1.3 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest HEMO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HEMO Market Data

Currency UK Pounds
Share Price 2.95p
Change Today 0.100p
% Change 3.51 %
52 Week High 4.25
52 Week Low 2.85
Volume 424,815
Shares Issued 356.04m
Market Cap 10.50m
RiskGrade 309

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average
Sector averageSector averageSector averageSector averageSector average
Value
21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 23-Oct-2018

Time Volume / Share Price
16:26 35,000 @ 3.05p
10:50 25,000 @ 3.00p
10:49 50,000 @ 3.10p
10:49 125,000 @ 3.00p
10:49 30,000 @ 3.02p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page